WallStSmart

Comcast Corp (CMCSA)vsThermo Fisher Scientific Inc (TMO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Comcast Corp generates 177% more annual revenue ($125.28B vs $45.20B). TMO leads profitability with a 15.1% profit margin vs 15.0%. TMO appears more attractively valued with a PEG of 1.56. CMCSA earns a higher WallStSmart Score of 64/100 (C+).

CMCSA

Buy

64

out of 100

Grade: C+

Growth: 4.0Profit: 7.0Value: 7.3Quality: 4.5
Piotroski: 6/9Altman Z: 1.48

TMO

Buy

62

out of 100

Grade: C+

Growth: 4.7Profit: 7.0Value: 4.0Quality: 5.3
Piotroski: 3/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CMCSAUndervalued (+69.5%)

Margin of Safety

+69.5%

Fair Value

$106.51

Current Price

$25.40

$81.11 discount

UndervaluedFair: $106.51Overvalued
TMOSignificantly Overvalued (-16.1%)

Margin of Safety

-16.1%

Fair Value

$408.60

Current Price

$465.00

$56.40 premium

UndervaluedFair: $408.60Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CMCSA5 strengths · Avg: 9.2/10
P/E RatioValuation
5.2x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Market CapQuality
$93.74B9/10

Large-cap with strong market position

Return on EquityProfitability
20.9%9/10

Every $100 of equity generates 21 in profit

Free Cash FlowQuality
$4.54B8/10

Generating 4.5B in free cash flow

TMO1 strengths · Avg: 9.0/10
Market CapQuality
$176.32B9/10

Large-cap with strong market position

Areas to Watch

CMCSA4 concerns · Avg: 2.3/10
Debt/EquityHealth
1.143/10

Elevated debt levels

PEG RatioValuation
142.982/10

Expensive relative to growth rate

EPS GrowthGrowth
-32.6%2/10

Earnings declined 32.6%

Altman Z-ScoreHealth
1.482/10

Distress zone — elevated risk

TMO3 concerns · Avg: 3.7/10
PEG RatioValuation
1.564/10

Expensive relative to growth rate

P/E RatioValuation
26.1x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CMCSA

The strongest argument for CMCSA centers on P/E Ratio, Price/Book, Market Cap.

Bull Case : TMO

The strongest argument for TMO centers on Market Cap. Profitability is solid with margins at 15.1% and operating margin at 17.9%.

Bear Case : CMCSA

The primary concerns for CMCSA are Debt/Equity, PEG Ratio, EPS Growth.

Bear Case : TMO

The primary concerns for TMO are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

CMCSA profiles as a value stock while TMO is a mature play — different risk/reward profiles.

TMO carries more volatility with a beta of 0.88 — expect wider price swings.

TMO is growing revenue faster at 6.2% — sustainability is the question.

CMCSA generates stronger free cash flow (4.5B), providing more financial flexibility.

Bottom Line

CMCSA scores higher overall (64/100 vs 62/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Comcast Corp

COMMUNICATION SERVICES · TELECOM SERVICES · USA

Comcast Corporation is an American telecommunications conglomerate headquartered in Philadelphia, Pennsylvania. It is the second-largest broadcasting and cable television company in the world by revenue (behind AT&T), the largest pay-TV company, the largest cable TV company and largest home Internet service provider in the United States, and the nation's third-largest home telephone service provider. Comcast provides services to U.S. residential and commercial customers in 40 states and in the District of Columbia. As the parent company of the international media company NBCUniversal since 2011, Comcast is a producer of feature films and television programs intended for theatrical exhibition and over-the-air and cable television broadcast, respectively.

Visit Website →

Thermo Fisher Scientific Inc

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.

Visit Website →

Want to dig deeper into these stocks?